Naringenin inhibits neointimal hyperplasia following arterial reconstruction with interpositional vein graft

Annals of Plastic Surgery

Volumn 64, Issue 1, 2010, Pages 105-113

  Cayci, Cenk ^a   Wahlquist, Trevor C ^b   Seckin, Serin I ^b   Ozcan, Vefa ^c   Tekinay, Ayse B ^d,e   Martens, Timothy P ^b   Oz, Mehmet C ^b   Ascherman, Jeffrey A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c PAMUKKALE UNIVERSITY   (Turkey)

^d ROCKEFELLER UNIVERSITY   (United States)

^e BILKENT UNIVERSITY   (Turkey)

Author keywords

Arterial reconstruction with interpositional vein graft; Naringenin; Neointimal hyperplasia

Indexed keywords

ANTIOXIDANT; FLAVANONE DERIVATIVE; NARINGENIN;

ANIMAL; ARTICLE; AUTOTRANSPLANTATION; DRUG ADMINISTRATION; DRUG EFFECT; FEMORAL ARTERY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; METHODOLOGY; PATHOLOGY; PLASTIC SURGERY; POSTOPERATIVE CARE; RAT; SPRAGUE DAWLEY RAT; TRANSPLANTATION; VEIN;

ANIMALS; ANTIOXIDANTS; DRUG ADMINISTRATION SCHEDULE; FEMORAL ARTERY; FLAVANONES; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; POSTOPERATIVE CARE; RATS; RATS, SPRAGUE-DAWLEY; RECONSTRUCTIVE SURGICAL PROCEDURES; TRANSPLANTATION, AUTOLOGOUS; TUNICA INTIMA; VEINS;

EID: 76149137421     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31819b03cd     Document Type: Article

References (45)

1. Allaire E, Clowes AW. Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. Ann Thorac Surg. 1997;63:582-591 (Pubitemid 27084610)
2. Wissler RW, Hiltscher L, Oinuma T. The lesions of atherosclerosis in the young. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven; 1996:475-489
3. Stary HC. The histological classification of atherosclerotic lesions in human coronary arteries. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven; 1996:463-474
4. Falk E, Shah PK, Fuster V. Pathogenesis of plaque disruption. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven; 1996:491-507
5. Booyse FM, Osikowicz G, Quarfoot AJ. Effects of chronic oral consumption of nicotine on the rabbit aortic endothelium. Am J Pathol. 1981;102:229-238
6. Boutet M, Bazin M, Turcotte H, et al. Effects of cigarette smoke on rat thoracic aorta. Artery. 1980;7:56-72
7. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992;339: 883-887
8. Fuster W, Bowie EJ, Lewis JC, et al. Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. J Clin Invest. 1978;61:722-730
9. Rectenwald JE, Moldawer LL, Huber TS, et al. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation. 2000;102:1697-1702
10. Zimmerman MA, Selzman CH, Reznikov LL, et al. Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury. Am J Physiol Regul Integr Comp Physiol. 2002;283:R505-R512
11. Andreakos ET, Foxwell BM, Brennan FM, et al. Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine Growth Factor Rev. 2002;13:299-313
12. Moriera R, Carlos I, Vilegas V. Release of intermediate reactive hydrogen peroxide by macrophage cells activated by natural products. Biol Pharm Bull. 2001;24:201-204
13. Yuting C, Rongliang C, Zhongjian J, et al. Flavinoids as superoxide scavengers and antioxidants. Free Radic Biol Med. 1990;9:19-21
14. Manthey JA. Biological properties of flavonoids pertaining to inflammation. Microcirculation. 2000;7:S29-S34
15. Wadsworth T, Dennis R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW264.7 macrophages. Biochem Pharmacol. 1999;57
16. Cho JY, Kim PS, Park J, et al. Inhibitor of tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW264.7 cells from Amorpha fruticosa. J Ethnopharmacol. 2000;70:127-133
17. Lyu SY, Park WB. Production of cytokine and NO by RAW 264.7 macrophages and PBMC in vitro incubation with flavonoids. Arch Pharm Res. 2005;28:573-581
18. Herath HM, Takano-Ishikawa Y, Yamaki K. Inhibitory effect of some flavonoids on tumor necrosis factor-alpha production in lipopolysaccharidestimulated mouse macrophage cell line J774.1. J Med Food. 2003;6:365-370
19. Liu X, Wang W, Hu H, et al. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells. Pharm Res. 2006;23:82-89
20. Luscher TF. The endothelium and cardiovascular disease-a complex relation. N Engl J Med. 1994;330:1081-1083
21. Chobanian AV. 1989 Corcoran lecture: adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension. 1990;15:666-674
22. Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27
23. Ackland RD. Microsurgery. A Practice Manual. St. Louis, MO: Mosby; 1980
24. Zhang S, Qin C, Safe SH. Flavonoids as aryl hydrocarbon receptor agonists/ antagonists: effects of structure and cell context. Environ Health Perspect. 2003;111:1877-1882
25. Kawakubo H, Ozawa S, Ando N, et al. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. Oncol Rep. 2005;14:1453-1459
26. Gotlieb AI, Langille BL. The role of rheology in atherosclerotic coronary artery disease. In: Ross R, Topol EJ, Fuster V, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven: 1996:595-606
27. Clinton SK, Underwood R, Hayes L, et al. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol. 1992;140:301-316
28. Rosenfeld ME, Yla-Herttuala S, Lipton BA, et al. Macrophage colonystimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol. 1992;140:291-300
29. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 1990;87:5134-5138
30. Dzau VJ, Gibbons GH, Cooke JP, et al. Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. Circulation. 1993;87: 705-719
31. Matsumoto A, Naito M, Itakura H, et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990;87:9133-9137
32. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A. 1987;84:6020-6024
33. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989;243:393-396
34. Peppel K, Zhang L, Huynh TT, et al. Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells reduces neointimal hyperplasia. J Mol Cell Cardiol. 2002;34:1399-1409
35. Zhang L, Freedman NJ, Brian L, et al. Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler Thromb Vasc Biol. 2004;24:470-476
36. Gay CG, Winkles JA. Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A. 1991;88:296-300
37. Galis ZS, Sukhova GK, Kranzhofer R, et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995;92:402-406
38. Lendon CL, Davies MJ, Born GV, et al. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis. 1991;87:87-90
39. Brody WR, Angeli WW, Kosek JC. Histologic fate of the venous coronary artery bypass in dogs. Am J Pathol. 1972;66:111-130
40. Faries PL, Marin ML, Veith FJ, et al. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J Vasc Surg. 1996;24:463-471
41. Crook MF, Newby AC, Southgate KM. Expression of intercellular adhesion molecules in human saphenous veins: effects of inflammatory cytokines and neointima formation in culture. Atherosclerosis. 2000;150:33-41
42. Sterpetti AV, Cucina A, Lepidi S, et al. Formation of myointimal hyperplasia and cytokine production in experimental vein grafts. Surgery. 1998;123:461-469
43. Koyama N, Hart CE, Clowes AW. Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res. 1994;75:682-691
44. Corson MA, Berk BC. Growth factors and the vessel wall. Heart Dis Stroke. 1993;2:166-170
45. Krasinski K, Spyridopoulos I, Kearney M, et al. In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. Circulation. 2001;104:1754-1756